Elemental Impurity Detection Technique in Fluorodeoxyglucose (18F) Using Inductively Coupled Plasma Mass Spectrometry: Development and Validation
https://doi.org/10.30895/1991-2919-2025-15-4-444-450
Abstract
INTRODUCTION. When developing and validating manufacturing of a product, Russian radiopharmaceutical manufacturers are required to detect ubiquitous impurities (Pb, As, Fe as well as other elements) causing contamination. At the stage of preliminary monitoring, Al, Cu, and Zn were found to most often contribute to fluorodeoxyglucose (18F) elemental contamination.
AIM. This study aimed to develop and validate a technique detecting Al, As, Cu, Fe, Pb, and Zn in fluorodeoxyglucose (18F) using inductively coupled plasma mass spectrometry (ICP-MS).
MATERIALS AND METHODS. The technique was developed on a model mixture simulating fluorodeoxyglucose (18F). A sample with minimum analysed impurities was used for validation; then varying amounts of standard analyte solutions were added. The content was determined using Agilent 7900 mass spectrometer. Signal intensities of the following isotopes (a.u.m.) were recorded: 27Al, 57Fe, 63Cu, 66Zn, 75As, and 208Pb.
RESULTS. The organic matrix was found to insignificantly affect elemental analysis. Due to matrix effect, NaCl reduced spike recovery of Al, Cu, Pb, and Zn to the level below 70%. When diluting model mixture tenfold, spike recovery of the analytes reached 90–101%. Correlation coefficients of element concentration — signal intensity linear dependences for the analytes exceeded 0.99. When estimating precision, RSD values did not exceed 10%.
CONCLUSIONS. A technique has been developed detecting Al, As, Cu, Fe, Pb, and Zn in fluorodeoxyglucose (18F) using ICP-MS. This technique considers influence of matrix components on quantification of target elements when preparing samples. Validation parameters of the technique comply with pharmacopoeial requirements.
Keywords
About the Authors
Yu. N. ShvetsovaRussian Federation
Yulia N. Shvetsova.
8/2 Petrovsky Blvd, Moscow 127051
A. A. Erina
Russian Federation
Alina A. Erina.
8/2 Petrovsky Blvd, Moscow 127051
V. M. Shchukin
Russian Federation
Viktor M. Shchukin - Cand. Sci. (Pharm.).
8/2 Petrovsky Blvd, Moscow 127051
N. E. Kuz'mina
Russian Federation
Natalia E. Kuz’mina - Dr. Sci. (Chem.).
8/2 Petrovsky Blvd, Moscow 127051
References
1. Arnaout A, Varela NP, Allarakhia M, et al. Baseline staging imaging for distant metastasis in women with stages I, II, and III breast cancer. Curr Oncol. 2020;27(2):e123–45. https://doi.org/10.3747/co.27.6147
2. Dolgushin MB, Mikhaylov AI, Gordeev SS. The role of PET/CT with 18F-fluorodeoxyglucose in detecting the progression of colorectal cancer in asymptomatic patients with elevated level of сarcinoembryonic antigen (literature review). Colorectal Oncology. 2019;9(2):11–5 (In Russ.). https://doi.org/10.17650/2220-3478-2019-9-2-11-15
3. Vali R, Alessio A, Balza R, et al. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/ CT for Oncology 1.0. J Nucl Med. 2021;62(1):99–110. https://doi.org/10.2967/jnumed.120.254110
4. Surti S. Radionuclide methods and instrumentation for breast cancer detection and diagnosis. Semin Nucl Med. 2013;43(4): 271–80. https://doi.org/10.1053/j.semnuclmed.2013.03.003
5. Shvetsova YuN, Erina AA, Shchukin VM, et al. Detecting elemental impurities by inductively coupled plasma mass spectrometry in Russian radiopharmaceuticals. Regulatory Research and Medicine Evaluation. 2025;15(4):434–43 (In Russ.). https://doi.org/10.30895/1991-2919-2025-15-4-434-443
6. Kilian K, Chabecki B, Kiec J, et al. Synthesis, quality control and determination of metallic impurities in F-fludeoxyglucose production process. Rep Pract Oncol Radiother. 2014; 19(1):22–31. https://doi.org/10.1016/j.rpor.2014.03.001
7. Kilian K, Pęgier M, Pękal A, Pyrzyńska K. Distribution and separation of metallic and radionuclidic impurities in the production of 18F-fluorodeoxyglucose. J Radioanal Nucl Chem. 2016; (307):1037–43. https://doi.org/10.1007/s10967-015-4328-6
8. Tavares AT, Martins PDA, Fukumori NT, et al. Multielemental determination of trace elements in radiopharmaceuticals produced at the radiopharmacy center using ICP-OES technique. In: International Nuclear Atlantic Conference (INAC 2013). Recife, PE (Brazil); 2013.
9. Muller ALH, Oliveira JSS, Mello PA, et al. Study and determination of elemental impurities by ICP-MS in active pharmaceutical ingredients using single reaction chamber digestion in compliance with USP requirements. Talanta. 2015;136:161–9. https://doi.org/10.1016/j.talanta.2014.12.023
10. Nicolaï M, Rosin C, Tousset N, Nicolai Y. Trace metals analysis in estuarine and seawater by ICP-MS using on line preconcentration and matrix elimination with chelating resin. Talanta. 1999;50(2):433–44. https://doi.org/10.1016/S0039-9140(99)00130-7
11. Colon M, Hidalgo M, Iglesias M. Correction strategies over spectral interferences for arsenic determination in aqueous samples with complex matrices by quadrupole ICP-MS. J Anal At Spectrom. 2009;24(4):518–21. https://doi.org/10.1039/B820898K
12. Choe KY, Gajek R. Determination of trace elements in human urine by ICP-MS using sodium chloride as a matrix-matching component in calibration. Anal Methods. 2016;8(37):6754–63. https://doi.org/10.1039/c6ay01877g
13. Kojo K, Oguri T, Tanaka T, et al. Inductively coupled plasma mass spectrometry performance for the measurement of key serum minerals: A comparative study with standard quantification methods. J Clin Lab Anal. 2025;39(2):e25140. https://doi.org/10.1002/jcla.25140
Supplementary files
Review
For citations:
Shvetsova Yu.N., Erina A.A., Shchukin V.M., Kuz'mina N.E. Elemental Impurity Detection Technique in Fluorodeoxyglucose (18F) Using Inductively Coupled Plasma Mass Spectrometry: Development and Validation. Regulatory Research and Medicine Evaluation. 2025;15(4):444-450. (In Russ.) https://doi.org/10.30895/1991-2919-2025-15-4-444-450